EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases

Lou Deneuville, Arthur Mageau, Marie Pierre Debray, Karim Sacre iD, Nathalie Costedoat-Chalumeau, Eric Hachulla, Yurdagul Uzunhan, Erwan Le Tallec iD, Jacques Cadranel, Sylvain Marchand Adam, David Montani, Martine Rémi-Jardin und 7 weitere

Respirology · 2024-08 · 29 (8) · 713-721

DOI: 10.1111/resp.14703 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respirology, online erschienen am 17.03.2024. Verfasst von Lou Deneuville und 18 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, PHERE, F-75018 Paris, et Hôpital Bichat, APHP, Service de Pneumologie A, Centre constitutif du centre de référence des…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Chronic interstitial lung disease (ILD) occurs rarely with systemic lupus erythematosus (SLE) as compared with other connective tissue diseases. This multicentric retrospective study of patients with SLE‐ILD from the OrphaLung and French SLE networks during 2005–2020 aimed to describe the characteristics of patients with SLE‐ILD and analyse factors associated with prognosis.

Methods

We analysed data for 89 patients with SLE‐ILD (82 women, 92.1%) (median age at SLE diagnosis: 35 years [interquartile range 27–47]). All patients met the 2019 EULAR/ACR criteria for the diagnosis of SLE.

Results

Forty two (47.2%) patients were positive for anti‐ribonuclear protein antibodies and 45 (50.6%) for anti SSA/Ro antibodies. A total of 58 (65.2%) patients had another connective tissue disease: Sjögren's syndrome ( n = 33, 37.1%), systemic sclerosis ( n = 14, 15.7%), inflammatory myopathy ( n = 6, 6.7%), or rheumatoid arthritis ( n = 6, 6.7%). ILD was diagnosed along with SLE in 25 (28.1%) patients and at a median of 6 (0–14) years after the SLE diagnosis. The most frequent CT pattern was suggestive of non‐specific interstitial pneumonia ( n = 41, 46.0%) with or without superimposed organizing pneumonia. After a median follow‐up of 86.5 [39.5–161.2] months, 18 (20.2%) patients had died and 6 (6.7%) underwent lung transplantation. The median 5‐year and 10‐year transplantation‐free survival were 96% (92–100) and 87% (78–97). In total, 44 (49.4%) patients showed ILD progression. Cutaneous manifestations and Raynaud's phenomenon were associated with better survival. Only forced vital capacity was significantly associated with survival and ILD progression.

Conclusion

ILD is a rare manifestation of SLE with good overall prognosis but with possible risk of ILD progression. Patients with SLE‐ILD frequently have another connective tissue disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialLupus Erythematosus, SystemicHumansFemaleMaleAdultRetrospective StudiesMiddle AgedPrognosisChronic DiseaseAntibodies, Antinuclear

Stichwörter der Autor:innen

connective‐tissue diseasedisease progressioninterstitial lung diseaselupusnon‐specific interstitial pneumoniapulmonary fibrosissurvival

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Université Paris Cité, Inserm, PHERE, F-75018 Paris, et Hôpital Bichat, APHP, Service de Pneumologie A, Centre constitutif du centre de référence des Maladies Pulmonaires Rares, FHU APOLLO, Paris, France.
  • Département de Médecine Interne, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Service de Radiologie, Hôpital Bichat Paris, Paris, France.
  • Département de Médecine Interne, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North and North-West of France (CeRAINO), CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE - Inst…
  • Service de Pneumologie, Centre constitutif du centre de référence des maladies pulmonaires rares, Hôpital Avicenne, INSERM U1272, Université Sorbonne Paris Nord, Bobigny, France.

ORCID-Profile: Karim Sacre, Erwan Le Tallec, Vincent Cottin, Raphael Borie

Zitieren

APA

Deneuville, L., Mageau, A., Debray, M. P., Sacre, K., Costedoat-Chalumeau, N., Hachulla, E., Uzunhan, Y., Le Tallec, E., Cadranel, J., Marchand Adam, S., Montani, D., Rémi-Jardin, M., Reynaud-Gaubert, M., Prevot, G., Beltramo, G., Crestani, B., Cottin, V., Borie, R., & OrphaLung Network (2024). Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases. Respirology, 29(8), 713-721. https://doi.org/10.1111/resp.14703

Vancouver

Deneuville L, Mageau A, Debray MP, Sacre K, Costedoat-Chalumeau N, Hachulla E, et al. Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases. Respirology. 2024;29(8):713-721. doi:10.1111/resp.14703

BibTeX
@article{Deneuville2024,
  author = {Deneuville, Lou and Mageau, Arthur and Debray, Marie Pierre and Sacre, Karim and Costedoat-Chalumeau, Nathalie and Hachulla, Eric and Uzunhan, Yurdagul and Le Tallec, Erwan and Cadranel, Jacques and Marchand Adam, Sylvain and Montani, David and Rémi-Jardin, Martine and Reynaud-Gaubert, Martine and Prevot, Gregoire and Beltramo, Guillaume and Crestani, Bruno and Cottin, Vincent and Borie, Raphael and OrphaLung Network, OrphaLung Network},
  title = {Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {8},
  pages = {713--721},
  doi = {10.1111/resp.14703}
}
Kostenlos starten →